CE Mark Approval Granted to Precision Biomonitoring's SARS-CoV-2 TRIPLELOCK™ Test
Retrieved on:
Thursday, October 29, 2020
GUELPH, Canada and BRUSSELS, Belgium, Oct. 29, 2020 /PRNewswire/ -- Today, Precision Biomonitoring announced it has received CE Mark for its TRIPLELOCK SARS-CoV-2 test in 96-Well Plate format.
Key Points:
- GUELPH, Canada and BRUSSELS, Belgium, Oct. 29, 2020 /PRNewswire/ -- Today, Precision Biomonitoring announced it has received CE Mark for its TRIPLELOCK SARS-CoV-2 test in 96-Well Plate format.
- The TRIPLELOCK 96-Well Plates are a cost-effective, scalable RT-PCR solution that detects the RNA of SARS-CoV-2 that causes COVID-19.
- "Precision Biomonitoring's innovative test will be a supportive solution as we address the immediate testing needs across Europe," says Greg Henderson, International Business Development Director, Precision Biomonitoring.
- Precision Biomonitoring's shelf-stableSARS-CoV-2 TRIPLELOCK96-Well Plates are an innovative testing solution that detects the RNA of severe acute respiratory syndrome COVID-19.